NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Caplin Point Laboratories Limited (NSE: CAPLIPOINT)
CAPLIPOINT Technical Analysis
2
As on 28th Mar 2024 CAPLIPOINT SHARE Price closed @ 1315.35 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1081.85 & Strong Sell for SHORT-TERM with Stoploss of 1421.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CAPLIPOINTSHARE Price
Open | 1274.00 | Change | Price | % |
High | 1329.95 | 1 Day | 52.25 | 4.14 |
Low | 1257.15 | 1 Week | 48.35 | 3.82 |
Close | 1315.35 | 1 Month | -136.85 | -9.42 |
Volume | 276479 | 1 Year | 731.20 | 125.17 |
52 Week High 950.60 | 52 Week Low 584.15 |
NSE INDIA Most Active Stocks
IDEA | 13.25 | -0.38% |
IDFCFIRSTB | 75.40 | -3.08% |
YESBANK | 23.20 | 0.22% |
GTLINFRA | 1.60 | 0.00% |
NHPC | 89.70 | 0.96% |
TATASTEEL | 155.85 | 2.06% |
BCG | 13.80 | -1.08% |
MAHABANK | 62.35 | 5.41% |
IRFC | 142.35 | -0.35% |
SOUTHBANK | 27.25 | -1.80% |
NSE INDIA Top Gainers Stocks
GOCLCORP | 454.60 | 19.99% |
NRL | 90.70 | 15.32% |
AEGISCHEM | 446.65 | 13.18% |
VIPIND | 525.50 | 12.89% |
REPRO | 834.35 | 12.02% |
GENESYS | 591.45 | 10.91% |
ONELIFECAP | 30.25 | 10.00% |
IFBIND | 1505.95 | 9.98% |
WEIZMANIND | 110.85 | 9.97% |
OMAXE | 90.55 | 9.96% |
NSE INDIA Top Losers Stocks
PERSISTENT | 3984.55 | -50.81% |
SITINET | 0.55 | -8.33% |
RACE | 325.10 | -6.35% |
RACE | 325.10 | -6.35% |
FCONSUMER | 0.75 | -6.25% |
KHANDSE | 29.35 | -6.23% |
CAMLINFINE | 89.25 | -6.10% |
ORIENTBELL | 347.15 | -6.06% |
KOHINOOR | 38.75 | -5.95% |
DWARKESH | 69.50 | -5.89% |
CAPLIPOINT Daily Charts |
CAPLIPOINT Intraday Charts |
Whats New @ Bazaartrend |
CAPLIPOINT Free Analysis |
|
CAPLIPOINT Important Levels Intraday
RESISTANCE | 1455.64 |
RESISTANCE | 1410.65 |
RESISTANCE | 1382.84 |
RESISTANCE | 1355.03 |
SUPPORT | 1275.67 |
SUPPORT | 1247.86 |
SUPPORT | 1220.05 |
SUPPORT | 1175.06 |
CAPLIPOINT Target March 2024
4th UP Target | 2117.19 |
3rd UP Target | 1887.3 |
2nd UP Target | 1745.19 |
1st UP Target | 1603.09 |
1st DOWN Target | 1197.61 |
2nd DOWN Target | 1055.51 |
3rd DOWN Target | 913.4 |
4th DOWN Target | 683.51 |
CAPLIPOINT Weekly Target
4th UP Target | 1387.69 |
3rd UP Target | 1349.53 |
2nd UP Target | 1325.94 |
1st UP Target | 1302.35 |
1st DOWN Target | 1235.05 |
2nd DOWN Target | 1211.46 |
3rd DOWN Target | 1187.87 |
4th DOWN Target | 1149.71 |
CAPLIPOINT Target2024
4th UP Target | 3002 |
3rd UP Target | 2474.17 |
2nd UP Target | 2147.9 |
1st UP Target | 1821.63 |
1st DOWN Target | 890.67 |
2nd DOWN Target | 564.4 |
3rd DOWN Target | 238.13 |
4th DOWN Target | -289.7 |
Caplin Point Laboratories Limited ( NSE INDIA Symbol : CAPLIPOINT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CAPLIPOINT Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is 35.25 | Sideways | |
MFI (14) | MFI is 35.74 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is -70.52 | Sideways | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 315.78 | |
10 Day Avg Volume | Traded -38.64 % Less then 10 Day Average Volume |
CAPLIPOINT Other Details
Segment | EQ | |
Market Capital | 65083342848.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
CAPLIPOINT Address
CAPLIPOINT Latest News
CAPLIPOINT Business Profile
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India. Address: Ashvich Tower, Chennai, India, 600096
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service